JP4327301B2 - 形質転換微生物、d−アミノアシラーゼの製造方法 - Google Patents
形質転換微生物、d−アミノアシラーゼの製造方法 Download PDFInfo
- Publication number
- JP4327301B2 JP4327301B2 JP17055599A JP17055599A JP4327301B2 JP 4327301 B2 JP4327301 B2 JP 4327301B2 JP 17055599 A JP17055599 A JP 17055599A JP 17055599 A JP17055599 A JP 17055599A JP 4327301 B2 JP4327301 B2 JP 4327301B2
- Authority
- JP
- Japan
- Prior art keywords
- aminoacylase
- gene
- zinc
- producing
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 101710097070 D-aminoacylase Proteins 0.000 title claims description 65
- 244000005700 microbiome Species 0.000 title claims description 46
- 238000004519 manufacturing process Methods 0.000 title claims description 31
- 108090000623 proteins and genes Proteins 0.000 claims description 52
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims description 27
- 239000011701 zinc Substances 0.000 claims description 24
- 229910052725 zinc Inorganic materials 0.000 claims description 24
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 23
- 238000012986 modification Methods 0.000 claims description 10
- 230000004048 modification Effects 0.000 claims description 10
- 238000013519 translation Methods 0.000 claims description 8
- 238000011144 upstream manufacturing Methods 0.000 claims description 8
- 239000002773 nucleotide Substances 0.000 claims description 5
- 125000003729 nucleotide group Chemical group 0.000 claims description 5
- 241001646716 Escherichia coli K-12 Species 0.000 claims description 3
- 239000013604 expression vector Substances 0.000 claims description 3
- 230000001747 exhibiting effect Effects 0.000 claims description 2
- 239000002609 medium Substances 0.000 description 44
- 230000000694 effects Effects 0.000 description 20
- 239000013612 plasmid Substances 0.000 description 17
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 16
- 241000588724 Escherichia coli Species 0.000 description 16
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 8
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 8
- 101710150975 N-acyl-L-amino acid amidohydrolase Proteins 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 239000000411 inducer Substances 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- 241000233866 Fungi Species 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 241001673062 Achromobacter xylosoxidans Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 2
- 235000019797 dipotassium phosphate Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 150000008574 D-amino acids Chemical class 0.000 description 1
- WXNXCEHXYPACJF-UHFFFAOYSA-N N-acetyl-leucine Chemical compound CC(C)CC(C(O)=O)NC(C)=O WXNXCEHXYPACJF-UHFFFAOYSA-N 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 150000003752 zinc compounds Chemical class 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17055599A JP4327301B2 (ja) | 1999-06-17 | 1999-06-17 | 形質転換微生物、d−アミノアシラーゼの製造方法 |
| PCT/JP2000/003932 WO2000078926A1 (fr) | 1999-06-17 | 2000-06-15 | Micro-organisme transforme et procede de production de d-aminoacylase |
| CNB008116105A CN100335615C (zh) | 1999-06-17 | 2000-06-15 | 转化微生物、d-酰化氨基酸水解酶的制备方法 |
| US10/009,782 US6943004B1 (en) | 1999-06-17 | 2000-06-15 | Transformed microorganism and process for producing D-aminoacylase |
| EP00937269A EP1188823B1 (en) | 1999-06-17 | 2000-06-15 | Transformed microorganism and process for producing d-aminoacylase |
| DE60042741T DE60042741D1 (de) | 1999-06-17 | 2000-06-15 | Transformierte mikroorganismen und verfahren zur herstellung von d-aminoacylase |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17055599A JP4327301B2 (ja) | 1999-06-17 | 1999-06-17 | 形質転換微生物、d−アミノアシラーゼの製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2001000185A JP2001000185A (ja) | 2001-01-09 |
| JP2001000185A5 JP2001000185A5 (enExample) | 2006-05-18 |
| JP4327301B2 true JP4327301B2 (ja) | 2009-09-09 |
Family
ID=15907041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP17055599A Expired - Fee Related JP4327301B2 (ja) | 1999-06-17 | 1999-06-17 | 形質転換微生物、d−アミノアシラーゼの製造方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6943004B1 (enExample) |
| EP (1) | EP1188823B1 (enExample) |
| JP (1) | JP4327301B2 (enExample) |
| CN (1) | CN100335615C (enExample) |
| DE (1) | DE60042741D1 (enExample) |
| WO (1) | WO2000078926A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020087948A (ko) * | 2001-02-01 | 2002-11-23 | 미쯔이가가꾸가부시끼가이샤 | 신규 d-아미노아실라제를 코딩하는 dna 및 그것을사용한 d-아미노산의 제조 방법 |
| EP1574568A4 (en) * | 2002-12-18 | 2006-10-11 | Daiichi Pure Chemicals Co Ltd | D-aminoacylase |
| EP1435388B1 (en) * | 2002-12-24 | 2012-12-12 | Daicel Corporation | D-aminoacylase mutants from Alcaligenes denitrificans for improved D-amino acid production. |
| JP4513967B2 (ja) * | 2005-03-17 | 2010-07-28 | 東洋紡績株式会社 | D−アミノアシラーゼの活性向上方法 |
| JP5334044B2 (ja) * | 2008-12-26 | 2013-11-06 | 学校法人立命館 | D−アミノアシラーゼ及びそれを用いたd−アミノ酸の製造方法 |
| CN108624577B (zh) * | 2017-03-22 | 2021-07-27 | 中国科学院天津工业生物技术研究所 | 用于催化n-乙酰-d-色氨酸水解生成d-色氨酸的新酶 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0691820B2 (ja) * | 1986-01-13 | 1994-11-16 | ナガセ生化学工業株式会社 | アミノアシラ−ゼ溶液の安定化法 |
| US5589386A (en) * | 1988-08-26 | 1996-12-31 | Serdar; Cuneyt M. | Hydrolysis of cholinesterase inhibitors using parathion hydrolase |
| JPH105488A (ja) * | 1996-06-21 | 1998-01-13 | Kiyoshi Okamura | お茶刈り袋の大型洗濯機 |
| JP4063400B2 (ja) * | 1997-07-31 | 2008-03-19 | ダイセル化学工業株式会社 | D−アミノアシラーゼ |
| JPH11318442A (ja) * | 1998-03-17 | 1999-11-24 | Daicel Chem Ind Ltd | D―アミノアシラ―ゼ |
| JP2000041684A (ja) * | 1998-07-29 | 2000-02-15 | Daicel Chem Ind Ltd | 新規なd−アミノアシラーゼおよびその製造方法、並びに該d−アミノアシラーゼを利用したd−アミノ酸の製造方法 |
-
1999
- 1999-06-17 JP JP17055599A patent/JP4327301B2/ja not_active Expired - Fee Related
-
2000
- 2000-06-15 CN CNB008116105A patent/CN100335615C/zh not_active Expired - Fee Related
- 2000-06-15 DE DE60042741T patent/DE60042741D1/de not_active Expired - Lifetime
- 2000-06-15 EP EP00937269A patent/EP1188823B1/en not_active Expired - Lifetime
- 2000-06-15 WO PCT/JP2000/003932 patent/WO2000078926A1/ja not_active Ceased
- 2000-06-15 US US10/009,782 patent/US6943004B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000078926A1 (fr) | 2000-12-28 |
| EP1188823A1 (en) | 2002-03-20 |
| CN100335615C (zh) | 2007-09-05 |
| US6943004B1 (en) | 2005-09-13 |
| CN1514876A (zh) | 2004-07-21 |
| EP1188823B1 (en) | 2009-08-12 |
| JP2001000185A (ja) | 2001-01-09 |
| EP1188823A4 (en) | 2003-01-22 |
| DE60042741D1 (de) | 2009-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2215783C2 (ru) | МУТАНТНАЯ N-АЦЕТИЛГЛУТАМАТ СИНТАЗА (ВАРИАНТЫ), ФРАГМЕНТ ДНК, ШТАММ БАКТЕРИИ Escherichia coli - ПРОДУЦЕНТ АРГИНИНА (ВАРИАНТЫ) И СПОСОБ ПОЛУЧЕНИЯ L-АРГИНИНА | |
| EP2196535B1 (en) | A method for producing l-arginine using a bacterium of enterobacteriaceae family, having attenuated expression of a gene encoding an l-arginine transporter | |
| CN113666991A (zh) | Yh66-rs07015基因改造得到的工程菌及其在制备缬氨酸中的应用 | |
| JP4327301B2 (ja) | 形質転換微生物、d−アミノアシラーゼの製造方法 | |
| KR102284730B1 (ko) | 신규한 수용성 피리딘 뉴클레오티드 트랜스수소효소 변이체 및 이를 이용한 l-트립토판 생산 방법 | |
| JP2526021B2 (ja) | 遺伝子的に修飾された生物体を使用するビタミンc先駆体の製造 | |
| KR102654301B1 (ko) | NADH:quinone 산화환원효소의 발현이 조절된 재조합 미생물 및 이를 이용한 O-포스포세린, 시스테인 및 이의 유도체의 생산방법 | |
| KR20220110412A (ko) | 신규한 단백질 변이체 및 이를 이용한 l-라이신 생산 방법 | |
| CN114181288B (zh) | 制备l-缬氨酸的方法及其所用的基因与该基因编码的蛋白质 | |
| CN114349831B (zh) | aspA基因突变体、重组菌及制备L-缬氨酸的方法 | |
| EP4644555A1 (en) | Galactose-1-phosphate uridyltransferase mutant and use thereof in preparation of l-lysine | |
| EP4293115A1 (en) | Polynucleotide having promoter activity and use thereof in production of traget compounds | |
| CN116515723A (zh) | PheP的活性增强及生产L-谷氨酸的方法 | |
| KR102284731B1 (ko) | 신규한 아이소시트르산 디하이드로게네이즈 키나아제/포스파타제 효소 변이체 및 이를 이용한 l-트립토판 생산 방법 | |
| KR20240152455A (ko) | 피루브산 탈수소효소 복합체 디히드로리포일리신-잔기 아세틸트랜스퍼라제의 활성이 증가된 미생물 및 이를 이용한 l-아미노산 생산 방법 | |
| KR102285951B1 (ko) | 시트레이트 신타아제의 활성이 약화된 신규한 변이형 폴리펩티드 및 이를 이용한 l-아미노산 생산 방법 | |
| KR20220110413A (ko) | 신규한 단백질 변이체 및 이를 이용한 l-라이신 생산 방법 | |
| CN114540399A (zh) | 一种制备l-缬氨酸的方法及其所用基因突变体和生物材料 | |
| JP2001000185A5 (enExample) | ||
| CN115500080A (zh) | 新型双功能亚甲基四氢叶酸脱氢酶/亚甲基四氢叶酸环水解酶变体及使用其生产xmp或gmp的方法 | |
| CN117264034B (zh) | Bbd29_09715基因突变体及其在制备l-谷氨酸中的应用 | |
| US20090186389A1 (en) | Microorganism whose activity of aspartate semialdehyde dehydrogenase is enhanced and the process for producing l-threonine using the microorganism | |
| CN114315998B (zh) | Cey17_rs00300基因突变体及其在制备l-缬氨酸中的应用 | |
| KR102284728B1 (ko) | 신규한 H(+)/Cl(-) 익스체인지 트랜스포터 변이체 및 이를 이용한 L-트립토판 생산 방법 | |
| WO2000037497A1 (fr) | Transporteur de sucre et gene le codant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060323 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060323 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080909 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081105 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090331 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090518 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090609 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090611 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120619 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120619 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130619 Year of fee payment: 4 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |